Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer

References

• Abbasalipourkabir R, Salehzadeh A, Abdullah R. (2016). Tamoxifen-loaded solid lipid nanoparticles-induced apoptosis in breast cancer cell lines. J Exp Nanosci 11:161–74.
   Web of Science ®Google Scholar
• Abdallah MH, Abu Lila AS, Unissa R, et al. (2021). Preparation, characterization and evaluation of anti-inflammatory and anti-nociceptive effects of brucine-loaded nanoemulgel. Colloids Surf B Biointerfaces 205:111868.
   PubMed Web of Science ®Google Scholar
• Abu Lila AS, Abdallah MH, Wani SUD, et al. (2021). Folic acid-conjugated raloxifene-loaded graphene-based nanocarrier: fabrication, characterization and antitumor screening. Colloids Surf A 625:126971.
   Web of Science ®Google Scholar
• Abu Lila AS, Soliman MS, Kiran HC, et al. (2021). Tamoxifen-loaded functionalized graphene nanoribbons for breast cancer therapy. J Drug Deliv Sci Technol 63:102499.
   Web of Science ®Google Scholar
• Al Saqr A, Khafagy ES, Alalaiwe A, et al. (2021a). Synthesis of gold nanoparticles by using green machinery: characterization and in vitro toxicity. Nanomaterials 11:808.
   Google Scholar
• Al Saqr A, Wani SUD, Gangadharappa HV, et al. (2021b). Enhanced cytotoxic activity of docetaxel-loaded silk fibroin nanoparticles against breast cancer cells. Polymers 13:1416.
   Google Scholar
• Bhosale RR, Osmani RAM, Abu Lila AS, et al. (2021). Ghatti gum-base graft copolymer: a plausible platform for pH-controlled delivery of antidiabetic drugs. RSC Adv 11:14871–82.
   PubMed Web of Science ®Google Scholar
• Chawla JS, Amiji MM. (2002). Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 249:127–38.
   PubMed Web of Science ®Google Scholar
• Chirila TV, Suzuki S, Papolla C. (2017). A comparative investigation of Bombyx mori silk fibroin hydrogels generated by chemical and enzymatic cross-linking. Biotechnol Appl Biochem 64:771–81.
   PubMed Web of Science ®Google Scholar
• Day CM, Hickey SM, Song Y, et al. (2020). Novel tamoxifen nanoformulations for improving breast cancer treatment: old wine in new bottles. Molecules 25:1182.
   Google Scholar
• Dyakonov T, Yang CH, Bush D, et al. (2012). Design and characterization of a silk-fibroin-based drug delivery platform using naproxen as a model drug. J Drug Deliv 2012:490514.
   PubMedGoogle Scholar
• Greish K. (2010). Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol 624:25–37.
   PubMedGoogle Scholar
• Grobmyer SR, Zhou G, Gutwein LG, et al. (2012). Nanoparticle delivery for metastatic breast cancer. Maturitas 73:19–26.
   PubMed Web of Science ®Google Scholar
• Hardy JG, Römer LM, Scheibel TR. (2008). Polymeric materials based on silk proteins. Polymer 49:4309–27.
   Web of Science ®Google Scholar
• Huang KW, Hsu FF, Qiu JT, et al. (2020). Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Sci Adv 6:eaax5032.
   PubMed Web of Science ®Google Scholar
• Jain AK, Swarnakar NK, Godugu C, et al. (2011). The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials 32:503–15.
   PubMed Web of Science ®Google Scholar
• Jordan VC. (2007). New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids 72:829–42.
   PubMed Web of Science ®Google Scholar
• Kundu J, Chung YI, Kim YH, et al. (2010). Silk fibroin nanoparticles for cellular uptake and control release. Int J Pharm 388:242–50.
   PubMed Web of Science ®Google Scholar
• Layek B, Mukherjee B. (2010). Tamoxifen citrate encapsulated sustained release liposomes: preparation and evaluation of physicochemical properties. Sci Pharm 78:507–15.
   PubMedGoogle Scholar
• Li H, Qiu H, Wang J, Sun Z. (2020). Erlotinib–silk fibroin nanoparticles in inhibiting tumor. Polym Bull 77:4325–34.
   Web of Science ®Google Scholar
• Li H, Tian J, Wu A, et al. (2016). Self-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinoma. Int J Nanomedicine 11:4373–80.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zheng Z, Gong H, et al. (2017). DNA preservation in silk. Biomater Sci 5:1279–92.
   PubMed Web of Science ®Google Scholar
• Lozano-Pérez AA, Gil AL, Pérez SA, et al. (2015). Antitumor properties of platinum(iv) prodrug-loaded silk fibroin nanoparticles. Dalton Trans 44:13513–21.
   PubMed Web of Science ®Google Scholar
• Łukasiewicz S, Mikołajczyk A, Błasiak E, et al. (2021). Polycaprolactone nanoparticles as promising candidates for nanocarriers in novel nanomedicines. Pharmaceutics 13:191.
   Google Scholar
• Luo Z, Li J, Qu J, et al. (2019). Cationized Bombyx mori silk fibroin as a delivery carrier of the VEGF165-Ang-1 coexpression plasmid for dermal tissue regeneration. J Mater Chem B 7:80–94.
   PubMed Web of Science ®Google Scholar
• Parkkari M, Paakkala AM, Salminen L, Holli K. (2003). Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study. Acta Ophthalmol Scand 81:495–9.
   PubMedGoogle Scholar
• Mathur AB, Gupta V. (2010). Silk fibroin-derived nanoparticles for biomedical applications. Nanomedicine (Lond) 5:807–20.
   PubMed Web of Science ®Google Scholar
• Montalbán MG, Coburn JM, Lozano-Pérez AA, et al. (2018). Production of curcumin-loaded silk fibroin nanoparticles for cancer therapy. Nanomaterials 8:126.
   Web of Science ®Google Scholar
• Mottaghitalab F, Farokhi M, Shokrgozar MA, et al. (2015). Silk fibroin nanoparticle as a novel drug delivery system. J Control Release 206:161–76.
   PubMed Web of Science ®Google Scholar
• Osborne CK, Boldt DH, Clark GM, Trent JM. (1983). Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 43:3583–5.
   PubMed Web of Science ®Google Scholar
• Osmani RA, Hani U, Bhosale RR, et al. (2017). Nanosponge carriers- an archetype swing in cancer therapy: a comprehensive review. Curr Drug Targets 18:108–18.
   PubMed Web of Science ®Google Scholar
• Pham DT, Tiyaboonchai W. (2020). Fibroin nanoparticles: a promising drug delivery system. Drug Deliv 27:431–48.
   PubMed Web of Science ®Google Scholar
• Qi Y, Wang H, Wei K, et al. (2017). A review of structure construction of silk fibroin biomaterials from single structures to multi-level structures. Int J Mol Sci 18:237.
   Google Scholar
• Riihimäki M, Thomsen H, Brandt A, et al. (2012). Death causes in breast cancer patients. Ann Oncol 23:604–10.
   PubMed Web of Science ®Google Scholar
• Roh YG, Shin SW, Kim SY, et al. (2019). Protein nanoparticle fabrication for optimized reticuloendothelial system evasion and tumor accumulation. Langmuir 35:3992–8.
   PubMed Web of Science ®Google Scholar
• Seib FP, Jones GT, Rnjak-Kovacina J, et al. (2013). pH-dependent anticancer drug release from silk nanoparticles. Adv Healthc Mater 2:1606–11.
   PubMed Web of Science ®Google Scholar
• Seib FP, Maitz MF, Hu X, et al. (2012). Impact of processing parameters on the haemocompatibility of Bombyx mori silk films. Biomaterials 33:1017–23.
   PubMed Web of Science ®Google Scholar
• Soliman WE, Khan S, Rizvi SM, et al. (2020). Therapeutic applications of biostable silver nanoparticles synthesized using peel extract of Benincasa hispida: antibacterial and anticancer activities. Nanomaterials 10:1954.
   Google Scholar
• Terada D, Yokoyama Y, Hattori S, et al. (2016). The outermost surface properties of silk fibroin films reflect ethanol-treatment conditions used in biomaterial preparation. Mater Sci Eng C Mater Biol Appl 58:119–26.
   PubMed Web of Science ®Google Scholar
• Tian Y, Jiang X, Chen X, et al. (2014). Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant cancer. Adv Mater 26:7393–8.
   PubMed Web of Science ®Google Scholar
• Vermeulen K, Berneman ZN, Van Bockstaele DR. (2003). Cell cycle and apoptosis. Cell Prolif 36:165–75.
   PubMed Web of Science ®Google Scholar
• Villemson A, Couvreur P, Gillet B, et al. (2006). Dextran-poly-ε-caprolactone micro- and nanoparticles: preparation, characterization and tamoxifen solubilization. J Drug Delivery Sci Technol 16:307–13.
   Web of Science ®Google Scholar
• Vishwa B, Moin A, Gowda DV, et al. (2021). Pulmonary targeting of inhalable moxifloxacin microspheres for effective management of tuberculosis. Pharmaceutics 13:79.
   Google Scholar
• Wang X, Yucel T, Lu Q, et al. (2010). Silk nanospheres and microspheres from silk/PVA blend films for drug delivery. Biomaterials 31:1025–35.
   PubMed Web of Science ®Google Scholar
• Wani SUD, Veerabhadrappa GH. (2018). Silk fibroin based drug delivery applications: promises and challenges. Curr Drug Targets 19:1177–90.
   PubMed Web of Science ®Google Scholar
• Wenk E, Merkle HP, Meinel L. (2011). Silk fibroin as a vehicle for drug delivery applications. J Control Release 150:128–41.
   PubMed Web of Science ®Google Scholar
• Wu P, Liu Q, Li R, et al. (2013). Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery. ACS Appl Mater Interfaces 5:12638–45.
   PubMed Web of Science ®Google Scholar
• Wu P, Liu Q, Wang Q, et al. (2018). Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth. Int J Nanomedicine 13:5405–18.
   PubMed Web of Science ®Google Scholar
• Xiao L, Lu G, Lu Q, Kaplan DL. (2016). Direct formation of silk nanoparticles for drug delivery. ACS Biomater Sci Eng 2:2050–7.
   PubMed Web of Science ®Google Scholar
• Yang Y, Du X, Wang Q, et al. (2019). Mechanism of cell death induced by silica nanoparticles in hepatocyte cells is by apoptosis. Int J Mol Med 44:903–12.
   PubMed Web of Science ®Google Scholar
• Yucel T, Lovett ML, Kaplan DL. (2014). Silk-based biomaterials for sustained drug delivery. J Control Release 190:381–97.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Li Y, Xie MB. (2015). Silk fibroin-based nanoparticles for drug delivery. Int J Mol Sci 16:4880–903.
   PubMed Web of Science ®Google Scholar